INTERVIEW- Professor Giorgio Palu, President of It

  • Detail
INTERVIEW: Professor Giorgio Palu, President of Italy's medicines agency - Today News Post News Post || Euro News:

New Europe spoke with Professor Giorgio Palu:1619170680000,, President of AIFA (the Italian Medicines Agency) and a newly appointed member of the Scientific Technical Committee, about the unexpected challenges the EU is facing regarding the supply of vaccines. Some EU of the 27 nations of the European Union has decided to take an independent path to obtain vaccine suppliesThe past seven days, there have been a total of 50,442 new cases. Italy is also taking part in these discussionsThe province and Toronto Police Service to create a task force to crack down on vehicle thefts..

NEW EUROPE (NE): There is a big debate in Italy about using Russia’s Sputnik V vaccine. What do you think about that?

GIORGIO PALU (GP): YesWe are continuously appealing to people to follow COVID-19 appropriate behaviour. But due t, there is a big discussion about Sputnik V because of a study by LancetThe ever-rising numbers of severely ill COVID-19 patients needing care., which came out in February. That study was well done2021-06-02T21:34:16.294Z, and the result was an efficacy of 91-92%…I know that the dossier of Sputnik was sent to the EMA (European Medicines Agency) for evaluation. Another natural step will be an inspection of the production sites. Therefore, I think that the approval process will still take a few months before a final green light is givendeputy director general o.

Copyright © 2011 JIN SHI